Skip to main content
SAGE Open Medical Case Reports logoLink to SAGE Open Medical Case Reports
. 2021 Jul 17;9:2050313X211027094. doi: 10.1177/2050313X211027094

Cryptococcus neoformans osteomyelitis of the calcaneus: Case report and literature review

Mauricio Esteban Ghioldi 1, Eric Daniel Dealbera 1, Lucas Nicolás Chemes 1, Gustavo Alejandro Caballero 2, Jorge Javier Del Vecchio 1,3,4,
PMCID: PMC8287342  PMID: 34350000

Abstract

Cryptococcus neoformans is an encapsulated, yeast-like fungus that can cause a systemic mycosis, particularly in immunocompromised patients. Disseminated infections typically affect the central nervous system, and osseous lesions are infrequent. Only 5%–10% of disseminated cryptococcosis involves bones. A 69-year-old female presented pain, swelling, and a soft tissue mass in her right lateral hindfoot. Her medical history included a kidney transplant (10 years earlier) secondary to chronic disease due to IgA nephropathy. The patient underwent an excisional biopsy, surgical debridement, and secondarily negative pressure wound therapy to achieve skin closure. Biopsy revealed a rare Cryptococcus neoformans osteomyelitis of the calcaneus. The patient then received IV treatment with liposomal amphotericin B at 3 mg/kg/d for 25 days. In conclusion, we present a case of cryptococcal osteomyelitis which, although not a frequent disease, must be considered as one of the differential diagnoses of osteolytic osseous lesions in patients with chronic osteomyelitis. Cryptococcus neoformans may be a potential cause of below-knee infection, mainly in immunocompromised patients.

Keywords: Orthopedics, rehabilitation, occupational therapy, radiology, pathology, Cryptococcus neoformans, calcaneus, osteomyelitis

Introduction

Cryptococcus neoformans is an encapsulated, yeast-like fungus that can cause systemic mycosis, particularly in immunocompromised patients (ICP).13 After inhalation, the organism may remain localized in the lungs or disseminate hematogenously, causing a systemic fungemia with numerous extrapulmonary infection sites. 4 ICP with sarcoidosis, Hodgkin’s disease, leukemia, and AIDS, and those with long-term use of corticosteroids are predisposed to develop cryptococcosis. 5

Disseminated infections typically affect the central nervous system, and osseous lesions are infrequent. Only 5%–10% of disseminated cryptococcosis involve bones. 6 It may affect immunocompetent patients in bone locations such as first metatarsal head, 7 talus, 8 vertebra, 9 iliac bone, 10 femur,11,12 and combination of sites.1315 Cryptococcosis may lead to significant morbidity and mortality since it may become fatal if not treated adequately. 16 More frequently, other microorganisms may cause calcaneal osteomyelitis (CO). A recent systematic review showed that Staphylococcus aureus was the most common organism involved. 17

To our knowledge, we report the first case of cryptococcal CO in an ICP. The patient was informed that data concerning the case would be submitted for publication, and consent was provided.

Case report

A 69-year-old female presented pain, swelling, and a soft tissue mass in her right lateral hindfoot; this symptom had presented for 2 months. She also had a persistent fever (38°C–39°C) for the previous 3 days, and the signs were not related to any injury or trauma.

Her medical history included a kidney transplant (10 years before) secondary to chronic disease due to IgA nephropathy. Also, she presented several episodes of urinary infection treated with antibiotics and double J catheter placement. Patients have been treated with deltisone (prednisone) (4 mg/day) as a transplant treatment.

On admission to our institution, her body temperature was 37°C, her heart rate was 106/min, and her blood pressure was 133/101 mm Hg. The peripheral blood white cell count was 2800 mm3 (58% neutrophils), and the erythrocyte sedimentation rate (ESR) was 28 m/h. Physical examination revealed a painful soft tissue mass (3 cm × 3 cm approximately) and tenderness in the lateral hindfoot on palpation, with associated pain when weight-bearing. The patient was tested for HIV, and the result was negative.

Radiographs showed a calcaneal tuberosity osteolytic lesion with marginal sclerosis and no associated periosteal reaction (Figure 1). No lesion was found on the chest X-ray. Magnetic resonance imaging (MRI) (T2-weighted) showed a 3.2 cm × 3.0 cm × 2.8 cm infiltrative hyperintense lesion with geographic margins. Posterolateral cortex erosion and significant bone and soft tissue edema were also observed (Figure 2).

Figure 1.

Figure 1.

(a) Preoperative soft tissue mass on lateral region of right calcaneus. (b) Preoperative lateral radiograph showing a lytic lesion on calcaneal tuberosity without periosteal reaction. No acute fracture was noted.

Figure 2.

Figure 2.

Sagittal (a) and axial (b) T2-weighted MRI showing a 3.2 cm × 3.0 cm × 2.8 cm infiltrative hyperintense lesion with geographic margins. Erosion of the posterolateral cortex and significant local edema. (c). Sagittal T1-weighted MRI.

Based on clinical examination and IMAGEN study results, excisional biopsy, surgical debridement, and secondarily negative pressure wound therapy (NPWT) were indicated. Intraoperatively, the lesion extended through the soft tissues and the underlying bone. Soft tissue found inside the cavitary was a soft, gray, mucoid, and gelatinous mass associated with purulent secretion (Figure 3). The lesion was removed, and the cystic bone defect was curetted until vital bone was obtained. Due to the soft tissue and bone defect, we used NPWT to achieve neovascularization and granulation.

Figure 3.

Figure 3.

(a) Gross specimens showing a soft, gray, mucoid, and gelatinous mass associated with purulent secretion. (b) Cavitary defect after complete resection of the lesion.

Cryptococcus neoformans was histologically found as spherical or yeast-like organisms within the cytoplasm of macrophages, and no granulomas were seen (Figure 4). The patient received IV treatment with liposomal amphotericin B at 3 mg/kg/d for 25 days, followed by oral 400 mg/d orally for 8 weeks.

Figure 4.

Figure 4.

(a) The histologic specimens showed the appearance of Cryptococcus neoformans into the cytoplasm of macrophages (arrow), hematoxylin and eosin staining (a) (×400), and periodic acid–Schiff (PAS) staining (inset) (×400) (b).

As a cavitary defect was generated, two-stage wound closure was designed. First, NPWT was used for 8 days to improve wound healing conditions. Although the extent of the defect was near the Achilles tendon insertion, immediate weight-bearing was allowed using a walker boot.

When the NPWT was removed, the skin was closed. The pain had progressively reduced at 2-year follow-up, and the patient was completely recovered and walking normally (Figure 5). MRI showed a slight decrease in the lesion size (Figure 6).

Figure 5.

Figure 5.

(a) Clinical image showing complete healed lesion. (b) Postoperative lateral radiograph at 1-year follow-up.

Figure 6.

Figure 6.

Sagittal (a) and axial (b) T2-weighted MRI showing a slight reduction of the hyperintense lesion.

Discussion

Cryptococcal opportunistic infections are quite frequent in ICP; hence, the diagnosis and treatment of osteomyelitis have become more challenging. 18 Sarcoidosis is the most common underlying condition associated with this infection, followed by tuberculosis and long-term use of corticosteroids. 19 The patient presented had been receiving corticosteroids for 10 years following a kidney transplant.

Although lungs and central nervous systems are the most frequently affected,2022 it may affect other tissues. 23 Only 5%–10% of disseminated cryptococcosis affects bones. 6 Cryptococcal osteomyelitis presumably occurs via hematogenous spread from a pulmonary focus, but direct inoculation through the skin is also possible.20,24 Spine infection is the most commonly reported osteomyelitis site, while other frequent sites are pelvis, femur, and ribs.20,21,23,25,26 We present an ICP with a rare or unique presentation of cryptococcal osteomyelitis on lower limb.

Based on analysis of published studies, the clinical presentation of the patient is invariable. Usually, patients show progressive soft tissue swelling and tenderness associated with systemic manifestations such as fever. 24 Also, most patients typically have normal white cell count and variably elevated ESR. In a recent review, only 7 of 39 cases patients were febrile. Before diagnosis, the median duration of symptoms was 3 months (range = 2 weeks to 33 months), and the leukocyte count was generally normal.20,23 Our patient showed soft tissue swelling and pain, but laboratory parameters were normal.

The radiographic appearance of cryptococcal osteomyelitis is consistently erosive or lytic with little or no periosteal reaction.19,26 While many of these lesions have well-defined geographic borders, this is not a constant finding. 27

Such features are not specific for cryptococcus and may be commonly shared by several conditions, including other infectious etiologies (such as other fungi, Actinomyces, mycobacteria, and Brucella) or neoplastic processes. Reliance on the presence of a periosteal reaction may be confusing. Several reports of patients with cryptococcal osteomyelitis were initially diagnosed as a malignant neoplastic process due to an extensive periosteal reaction.19,28 Also, cortical destruction with an associated purulent soft tissue fluid collection is frequent. 11 This case showed the characteristics mentioned (lytic, no periosteal reaction, and cortical destruction) associated with a purulent soft tissue mass.

Published studies indicate surgical debridement associated with antifungal therapy as a curative treatment for cryptococcal osteomyelitis.23,24 In reported cases, antifungals alone and rarely surgical debridement alone have demonstrated a healing effect.20,29 The primary goals of surgical intervention are to lessen the infectious burden and to avoid adjacent soft tissue involvement. This is achieved by removing the bony sequestrum and carefully debride the surrounding soft tissue affected. This patient was treated with surgical debridement associated with antifungal therapy with the addition of NPWT. NPWT is a widely used technology in acute, 30 chronic and postoperative wounds,31,32 and chronic osteomyelitis.3335 It provides moist wound conditions, reduces exudate, control wound-bed infection, and stimulates granulation. 36 Secondary wound closure was done after removal of NPWT. Although partial and total calcanectomies or even amputation may be suitable for treating other types of CO, we decided to do a conservative surgical procedure (because of size and low fracture risk) to preserve function. A more radical treatment was deferred if the clinical evolution was not as expected.17,37 Reported lower limb cases and outcomes are summarized in Table 1.

Table 1.

Published reports of osteomyelitis caused by Cryptococcus neoformans on the lower limb.

First author (year) Age (year) Sex Relevant MRI findings Bone involved Treatments Medications
Risk factors/comorbidities
Current case 69 F Kidney transplant, urinary infection (several) Intraosseous abscess, cavitary defect Calcaneus Deep debridement, VAC, secondary skin closure Amphotericin B 3 m
Ahn (2017) 7 42 F None Intraosseous abscess, metatarsal osteomyelitis First metatarsal head Deep debridement (intramedullary abscess drained, cancellous portion removed) Fluconazole 6 m
Increased inflammatory response in surrounding soft tissue Intramedullary defect packed with allogeneic bone graft
Delat (2016) 13 18 M None Tibia, scapula Debridement, saucerization, bone grafting Amphotericin B injection, flucytosine 14 days, fluconazole 9 m
Jacobson (2012) 11 27 M Drugs abuse (heroin) Intramedullary proximal femur lesion, extensive peripheral edema Femur Curettage, filled with calcium sulfate, bone grafting Intravenous vancomycin and zosyn, then fluconazole 400 mg daily for 6 months and augmentin 875 mg twice daily for 6 weeks
Balaji (2011) 8 51 M Kidney transplant (12 years), corticosteroid, and immunosuppressive therapy Talus Deep debridement Liposomal amphotericin B and 25 mg/kg/day (dose regulated according to creatinine clearance) of the fluorinated pyrimidine
Jou (2011) 14 50 M Diabetes mellitus type 2 Femur: anterior cortical destruction and periosteal infiltration Femur, ribs Excisional curettage, cemented hemiarthroplasty Fluconazole was administered intravenously (400 mg qds for 4 weeks, followed by 200 mg qds for 18 weeks)
Zainal (2011) 12 37 M Pulmonary tuberculosis (remission 4 years before presentation) Femur Deep debridement, curettage IV amphotericin B, oral fluconazole 6 weeks

Given the suspicion for disseminated disease, surgery should always be followed by appropriate chemotherapy. Antifungal chemotherapy usually includes a combination of amphotericin B and 5-flucytosine or fluconazole. 38 Single-agent therapy is generally avoided since secondary drug resistance has been reported. 23 The duration of chemotherapy needed for remission is not well determined and should be based on clinical and radiological improvement.20,23 The patient presented received amphotericin B without presenting adverse effects.

Conclusion

In conclusion, we present a case of cryptococcal osteomyelitis, which, although not a frequent disease, must be considered one of the differential diagnoses of osteolytic osseous lesions in patients with chronic osteomyelitis. It is a rare but treatable disease, particularly in immunocompromised hosts, in whom it may lead to significant morbidity and mortality. We believe that surgical debridement combined with systemic antifungal chemotherapy is the treatment of choice. NPWT is a helpful tool to treat chronic infections with cavitary defects.

Acknowledgments

All authors are equally conceived and designed the study, conducted research, provided research materials and collected and organized data, and analyzed and interpreted data.

Footnotes

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical approval: Our institution does not require ethical approval for reporting individual cases or case series.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

Informed consent: Written informed consent was obtained from the patient(s) for their anonymized information to be published in this article.

ORCID iD: Jorge Javier Del Vecchio Inline graphic https://orcid.org/0000-0001-5263-7626

References

  • 1. Chen WA, Emory CL, Graves BR. Disseminated cryptococcal osteomyelitis to the hand in an immunosuppressed lymphoma patient. J Hand Surg Am 2018; 43(3): 291.e1–291.e6. [DOI] [PubMed] [Google Scholar]
  • 2. Yigit N, Wu WW, Covey S, et al. Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma. Int J Hematol 2015; 101(3): 211–212. [DOI] [PubMed] [Google Scholar]
  • 3. Pudipeddi AV, Liu K, Watson GF, et al. Cryptococcal osteomyelitis of the skull in a liver transplant patient. Transpl Infect Dis 2016; 18(6): 954–956. [DOI] [PubMed] [Google Scholar]
  • 4. Denham ST, Brown JCS. Mechanisms of pulmonary escape and dissemination by Cryptococcus neoformans. J Fungi 2018; 4(1): 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Abdul-Karim FW, Pathria MN, Heller JG, et al. Case report 664. Skeletal Radiol 1991; 20: 227–229. [DOI] [PubMed] [Google Scholar]
  • 6. Sethi S. Cryptococcal osteomyelitis in the ribs. J Glob Infect Dis 2010; 2(1): 63–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ahn JH, Park C, Lee CW, et al. Cryptococcal osteomyelitis of the first metatarsal head in an immunocompetent patient. J Am Podiatr Med Assoc 2017; 107(3): 248–252. [DOI] [PubMed] [Google Scholar]
  • 8. Balaji GG, Mathuram AJ, Arockiaraj J, et al. A rare case of cryptococcal infection of talus with pathological fracture that healed with medical management. J Foot Ankle Surg 2011; 50(6): 740–743. [DOI] [PubMed] [Google Scholar]
  • 9. Nankeu S, Djaha JM, Saint Marcoux B, et al. Disseminated cryptococcosis revealed by vertebral osteomyelitis in an immunocompetent patient. Joint Bone Spine 2012; 79(6): 629–631. [DOI] [PubMed] [Google Scholar]
  • 10. Sang J, Yang Y, Fan Y, et al. Isolated iliac cryptococcosis in an immunocompetent patient. Plos Negl Trop Dis 2018; 12(3): e0006206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Jacobson ME, Griesser MJ, Paloski MD, et al. Isolated Cryptococcus neoformans osteomyelitis of the proximal femur: a case report and review of literature. Orthop Surg 2012; 4(3): 190–193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Zainal AI, Wong SL, Pan KL, et al. Cryptococcal osteomyelitis of the femur: a case report and review of literature. Trop Biomed 2011; 28(2): 444–449. [PubMed] [Google Scholar]
  • 13. Delat R, Laheri V. Bifocal cryptococcal osteomyelitis in an immunocompetent male. J Orthop Case Rep 2016; 6(5): 17–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Jou HJ, Lee FT, Wang MN, et al. Bifocal cryptococcal osteomyelitis: management of a patient with concurrent femur and rib infections. Hip Int 2011; 21(4): 495–497. [DOI] [PubMed] [Google Scholar]
  • 15. Zhang Y, Yu YS, Tang ZH, et al. Cryptococcal osteomyelitis of the scapula and rib in an immunocompetent patient. Med Mycol 2012; 50(7): 751–755. [DOI] [PubMed] [Google Scholar]
  • 16. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103(4): 533–538. [DOI] [PubMed] [Google Scholar]
  • 17. Sabater-Martos M, Sigmund IK, Loizou C, et al. Surgical treatment and outcomes of calcaneal osteomyelitis in adults: a systematic review. J Bone Jt Infect 2019; 4(3): 146–154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Ferry JA, Pettit CK, Rosenberg AE, et al. Fungi in megakaryocytes. Am J Clin Pathol 1991; 96(5): 577–581. [DOI] [PubMed] [Google Scholar]
  • 19. Witte DA, Chen I, Brady J, et al. Cryptococcal osteomyelitis. Report of a case with aspiration biopsy of a humeral lesion with radiologic features of malignancy. Acta Cytol 2000; 44(5): 815–818. [DOI] [PubMed] [Google Scholar]
  • 20. Behrman RE, Masci JR, Nicholas P. Cryptococcal skeletal infections: case report and review. Rev Infect Dis 1990; 12(2): 181–190. [DOI] [PubMed] [Google Scholar]
  • 21. Chleboun J, Nade S. Skeletal cryptococcosis. J Bone Joint Surg 1977; 59: 509–514. [PubMed] [Google Scholar]
  • 22. Hammerschlag MR, Domingo J, Haller JO, et al. Cryptococcal osteomyelitis: report of a case and a review of the literature. Clin Pediatr 1982; 21: 109–112. [DOI] [PubMed] [Google Scholar]
  • 23. Goldshteyn N, Zanchi A, Cooke K, et al. Cryptococcal osteomyelitis of the humeral head initially diagnosed as avascular necrosis. South Med J 2006; 99(10): 1140–1141. [DOI] [PubMed] [Google Scholar]
  • 24. Raftopoulos I, Meller JL, Harris V, et al. Cryptococcal rib osteomyelitis in a pediatric patient. J Pediatr Surg 1998; 33(5): 771–773. [DOI] [PubMed] [Google Scholar]
  • 25. Bryan CS. Vertebral osteomyelitis due to Cryptococcus neoformans. Case Report. J Bone Joint Surg Am 1977; 59: 275–276. [PubMed] [Google Scholar]
  • 26. Burch KH, Fine G, Quinn EL, et al. Cryptococcus neoformans as a cause of lytic bone lesions. JAMA 1975; 231(10): 1057–1059. [PubMed] [Google Scholar]
  • 27. Amenta PS, Stead J, Kricun ME. Case report 226: isolated Cryptococcus neoformans osteomyelitis of femur. Skeletal Radiol 1983; 9(4): 263–265. [DOI] [PubMed] [Google Scholar]
  • 28. Ganjei P, Evans DA, Fischer ML. Diagnosis of cryptococcal osteomyelitis by fine needle aspiration cytology: a case report. Acta Cytol 1982; 26(2): 224–226. [PubMed] [Google Scholar]
  • 29. Liu PY. Cryptococcal osteomyelitis: case report and review. Diagn Microbiol Infect Dis 1998; 30: 33–35. [DOI] [PubMed] [Google Scholar]
  • 30. Sahebally SM, McKevitt K, Stephens I, et al. Negative pressure wound therapy for closed laparotomy incisions in general and colorectal surgery: a systematic review and meta-analysis. JAMA Surg 2018; 153(11): e183467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev 2018; 2018(10): CD010318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Pachowsky M, Gusinde J, Klein A, et al. Negative pressure wound therapy to prevent seromas and treat surgical incisions after total hip arthroplasty. Int Orthop 2012; 36(4): 719–722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Narayan N, Edwards D, Ragoowansi RH. Glove and PICO: a novel technique for treatment of chronic wound due to osteomyelitis of the hand. BMJ Case Rep 2014; 2014: bcr2013202780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Narayana Kurup JK, Singasani R, Mohanty SP. Rare case of disseminated rhinosporidiosis with chronic osteomyelitis of the calcaneum treated by a simple technique of negative pressure wound therapy. BMJ Case Rep 2017; 2017: bcr2017221786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Yingling JM, Sun L, Yoon R, et al. A rare case of Candida parapsilosis osteomyelitis: a literature review and proposed treatment algorithm. Patient Saf Surg 2017; 11: 31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Apelqvist J, Willy C, Fagerdahl AM, et al. EWMA document: negative pressure wound therapy. J Wound Care 2017; 26(Sup. 3): S1–S154. [DOI] [PubMed] [Google Scholar]
  • 37. Yammine K, El-Alam A, Assi C. Outcomes of partial and total calcanectomies for the treatment of diabetic heel ulcers complicated with osteomyelitis. A Systematic Review and Meta-analysis. Foot Ankle Surg. Epub ahead of print 12 August 2020. DOI: 10.1016/j.fas.2020.07.014. [DOI] [PubMed] [Google Scholar]
  • 38. Utz JP, Garriques IL, Sande MA, et al. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis 1975; 132: 368–373. [DOI] [PubMed] [Google Scholar]

Articles from SAGE Open Medical Case Reports are provided here courtesy of SAGE Publications

RESOURCES